Sickle cell disease trials redefined: Toward unified clinical endpoints through international consensus

Research
Written By Christine Briscoe

Authors: Mohamed Yassin, Nirmish Shah, Andrew Campbell, Salam Al-Kindi, Wally Smith, Charles Jonassaint, Miguel Abboud, Raffaella Colombatti, Dipty Jain, Halima Bello-Manga, Mariane de Montalembert, Ana Silva-Pinto, Steven Okoli, Abdelaziz Fahem, Biree Andemariam

Published: November 3, 2025

Click Here to Read More
Christine Briscoe
Previous

Clinical and laboratory findings in adults with sickle cell disease which increase risk for severe acute chest syndrome
Next

Qualitative interviews exploring the patient experience of fatigue in individuals with sickle cell disease (SCD), thalassemia, and pyruvate kinase (PK) deficiency